Skip to main content

Table 1 Novel epilepsy gene discoveries from 2012 to 2015

From: Advancing epilepsy genetics in the genomic era

Gene

Phenotype(s)

Number of casesa

References

Chromatin remodeling

  

CHD2

EOEE, LGS, EE, ASD

>20

[28, 44–46, 87]

Ion channels and neurotransmitter receptors

 

GABRA1

DS, IS, JME, CAE, GGE

>10

[42, 46, 88–90]

GABRB3

IS, LGS

4

[46]

GRIN2A

LKS, CSWS, BECTS, ABPE, EE

>50

[91–97]

GRIN2B

IS, LGS, FE/ID, ID, ASD

>10

[46, 49, 54, 98]

HCN1

EOEE

4

[40]

KCNB1

IS

4

[43, 68]

KCNA2

EE

6

[99]

KCNC1

PME

13b

[100]

KCNQ2

BFNS, EOEE, EE

>50

[9, 72, 101–104]

KCNT1

MPSI, ADNFLE

14

[81, 105–108]

SCN8A

EE, EOEE

>30

[35, 37–39, 108]

SLC6A1

MAE

6

[30]

Intracellular signaling

  

GNAO1

OS, IS, EE

6

[68, 109]

SYNGAP1

EE, ID, ASD

>20

[28, 54, 110, 111]

TBC1D24

MPSI, DOORS, EOEE, FE + ID, FIME, PME

>15

[100, 112–118]

Metabolism

   

CERS1

PME

1a

[119]

SLC13A5

EOEE

3a

[120]

SLC25A22

NEESBs, MPSI, EME

4a

[121–124]

SLC35A2

EOEE, IS

8

[68, 125, 126]

Synaptic vesicle cycle

  

DNM1

IS, LGS

5

[68]

NECAP1

EOEE

1a

[127]

SNAP25

EE

1

[128]

STX1B

Fever-associated epilepsy

6

[129]

STXBP1

EOEE, OS, IS, DS, EE

>50

[42, 130–137]

mTOR signaling

  

DEPDC5

FFEVF, ADNFLE, BECTS, FCD, HME

>40

[58–64]

MTOR

FCD

18

[66, 138]

Multiple functions

  

ALG13

IS, LGS

4

[46, 54, 134]

EEF1A2

IS, EOEE, ASD, ID, microcephaly

4

[54–56]

PURA

EOEE

15

[31, 32]

WWOX

EOEE, microcephaly

8a

[139–142]

  1. ABPE atypical benign partial epilepsy, ADNFLE autosomal dominant nocturnal frontal lobe epilepsy, ASD autism spectrum disorder, BECTS benign epilepsy with centrotemporal spikes, BFNS benign familial neonatal seizures, CAE childhood absence epilepsy, CSWS continuous spike and waves during sleep, DOORS deafness, onychodystrophy, osteodystrophy, mental retardation and seizures syndrome, DS Dravet syndrome, EE epileptic encephalopathy, EME early myoclonic encephalopathy, EOEE early onset epileptic encephalopathy, FE focal epilepsy, FFEVPF familial focal epilepsy with variable foci, FIME familial infantile myoclonic epilepsy, GGE genetic generalized epilepsy, HME hemimegalencephaly, ID intellectual disability, IS infantile spasms, JME juvenile myoclonic epilepsy, LGS Landau–Kleffner syndrome, MAE myoclonic astatic epilepsy, MPSI migrating partial seizures of infancy, NEESBs neonatal epileptic encephalopathy with suppression bursts, OS Ohtahara syndrome, PME progressive myoclonus epilepsy.
  2. aRefers to the number of families for recessive genes or isolated cases with respect to recurrent mutations.
  3. bUnrelated probands have the same recurrent mutation (KCNC1 p.Arg320His), demonstrated to be de novo in 9/13.